Mitogen-activated protein kinase kinase

Mitogen-activated protein kinase kinase (MAPKK), also known as MEK (MAPK/ERK kinase), is a crucial enzyme in the MAPK/ERK pathway. This kinase is part of a signaling cascade that is essential for various cellular processes, including cell growth, differentiation, and apoptosis.

Structure and Function

MAPKK is a dual-specificity kinase, meaning it can phosphorylate both serine/threonine and tyrosine residues. It specifically phosphorylates and activates Mitogen-activated protein kinase (MAPK), which then translocates to the nucleus to regulate the activity of various transcription factors.

Activation Mechanism

MAPKK is activated by upstream kinases known as MAP kinase kinase kinases (MAPKKKs or MEKKs). Upon activation, MAPKK phosphorylates MAPK on specific threonine and tyrosine residues within the activation loop, leading to MAPK activation.

Isoforms

There are two main isoforms of MAPKK in mammals: MEK1 and MEK2. Both isoforms are ubiquitously expressed and have overlapping but distinct functions in the MAPK/ERK pathway.

Role in Disease

Dysregulation of MAPKK activity has been implicated in various diseases, including cancer, neurodegenerative diseases, and inflammatory disorders. In particular, mutations in the genes encoding MEK1 and MEK2 can lead to uncontrolled cell proliferation and tumorigenesis.

Inhibitors

Several small molecule inhibitors targeting MEK1 and MEK2 have been developed for therapeutic purposes. These inhibitors are used in the treatment of certain types of cancer, such as melanoma and non-small cell lung cancer.

Related Pages

• Mitogen-activated protein kinase
• MAPK/ERK pathway
• Cell signaling
• Protein kinase
• Signal transduction
• Apoptosis
• Cancer